Mallinckrodt Medical Inc

By: Bubbajunk.com

Mallinckrodt was founded in 1867 by Emil, Edward, Otto, and Gustov Mallinckrodt, in St. Louis, Mo. The company has grown through a number of mergers and acquisitions, most recently being purchased by Tyco International in 2000.
 
Mallinckrodt has been known as a pharmaceutical and specialty chemical company. Some of its early products included commercial reagents used to test the purity of other chemicals; opium-based narcotics used for pain relief; and ether purification to decrease contaminants and allow ether to be used as a safe anesthetic.
 
MallinckrodtÂâ€Ã¢„¢s structure today has evolved to that of a global healthcare manufacturer and marketer with vital products that sustain breathing, diagnose disease and relieve pain. Mallinckrodt's three business divisions, respiratory, imaging and pharmaceuticals, employ more than 12,000 employees worldwide, with operations in more than 100 countries.
 
The companyÂâ€Ã¢„¢s headquarters city, St. Louis, Mallinckrodt continues to be a significant presence, employing nearly 2,500 area residents who work in seven different locations around the region. MallinckrodtÂâ€Ã¢„¢s renewed commitment to organic growth was the impetus for numerous expansion projects in 2005, including a new 65,000 square foot pharmaceutical R&D lab in Webster Groves, which supports MallinckrodtÂâ€Ã¢„¢s Pharmaceuticals business, enabling greater capabilities to simultaneously develop new products.
 
The company employee volunteer program and community partnership program, Mallinckrodt makes ongoing efforts to place its leaders on boards of local non-profit agencies and organizations, where they can apply their knowledge and experience to enhance the effectiveness of an agency's or institution's operations.
 
The companyÂâ€Ã¢„¢s mission is to improve healthcare for patients worldwide by providing superior products that sustain breathing, diagnose disease and relieve pain. The company is committed to producing products that bring better healthcare to patients, more value to medical professionals, greater opportunity to employees, and increased earnings to reward Tyco shareholders.